Adaptation of finnish diabetes risk score for screening undiagnosed diabetes and hyperglycemia in Chinese adults
Jian Zhang, Jiating Wang, Fang Huang, Vanessa Caroline Campos, Hao Huang, Andreas Rytz, Yumeng Li, Wei Hu, Christian Darimont, Kai Yu, Yu-ming Chen

TL;DR
Researchers adapted a diabetes risk score originally developed in Finland to better screen for undiagnosed diabetes and high blood sugar in Chinese adults.
Contribution
The study introduces a modified diabetes risk model tailored for Chinese populations, showing improved screening performance compared to the original Finnish model.
Findings
The ModChinese model outperformed the original FINDRISC in detecting diabetes and hyperglycemia in Chinese adults.
The modified model showed higher sensitivity and specificity for diabetes screening in both training and validation datasets.
The prevalence of undiagnosed diabetes was 8.6% in the training dataset and 3.1% in the validation dataset.
Abstract
China has the largest population with diabetes globally, with over half of the cases going undiagnosed, highlighting the need for improved screening efforts. This study aimed to adapt the Finnish Diabetes Risk Score (FINDRSC), a widely used tool for assessing diabetes risk without relying on clinical indicators, for screening undiagnosed hyperglycemia and diabetes among Chinese adults. Data from the China Health and Nutrition Survey (CHNS), collected in the 2009 wave, were utilized as the training data (n = 7277), and data from the Guangzhou Nutrition and Health Study (GNHS, n = 2970), conducted in the years 2011–2014, were used for validation. Diabetes was defined as fasting plasma glucose (FPG) ≥ 7.0 mmol/L and/or glycated hemoglobin A1c (HbA1c) ≥ 6.5%. Hyperglycemia was defined as FPG ≥ 5.6 mmol/L and/or HbA1c ≥ 5.7%. Predictors in the original FINDRISC model were adjusted according…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDiabetes, Cardiovascular Risks, and Lipoproteins · Metabolism, Diabetes, and Cancer · Diabetes Management and Research
